11 results
Pulmonary and Non-Pulmonary Causes of ARDS #Diagnosis #EM #PCC #ARDS #Differential #Algorithm #Pulmonary #NonPulmonary #Causes #Ddxof
Pulmonary and Non-Pulmonary ... Causes of ARDS #Diagnosis ... #EM #PCC #ARDS ... #Differential #Algorithm ... #Causes #Ddxof
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
and Management ... Limb ischemia Pulmonary ... COPD, asthma, CF, PCP ... #ChestPain #Diagnosis ... #Management #Algorithm
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... of Suspected Pulmonary ... Embolism #Diagnosis ... #EM #IM #PCC #PulmonaryEmbolism ... #Ddxof
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
Algorithm for patients ... revascularization (PCI ... Stable #Angina #ChestPain ... #Diagnosis #Management ... #Algorithm #Cardiology
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Pulmonary Embolism ... 30d mortality #Diagnosis ... #Management #EM ... #IM #PCC #PESI ... #sPESI #risk #score
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
algorithm to determine ... Recent PCI/stenting ... since elective PCI ... medical and surgical management ... stratification #diagnosis
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Attempt if high risk ... Imaging: CXR- pulmonary ... opacities • Diagnosis ... fluid overload, PCC ... #management #hematology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pneumonia • DM risk ... Lung Abscess Management ... Clindamycin in case of PCN ... Lung #Abscess #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Tuberculosis Diagnosis ... staining, NAA (PCR ... Inhibitor: • Risk ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Tuberculosis Diagnosis ... staining, NAA (PCR ... Inhibitor: • Risk ... #Management #Treatment